The WEISS Lab


Pathophysiology of Ion Channels

Transcriptomic analysis of glycan-processing genes in the dorsal root ganglia of diabetic mice and functional characterization on Cav3.2 channels


Journal article


Robin N Stringer, J. Lazniewska, N. Weiss
Channels, 2020

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA
Stringer, R. N., Lazniewska, J., & Weiss, N. (2020). Transcriptomic analysis of glycan-processing genes in the dorsal root ganglia of diabetic mice and functional characterization on Cav3.2 channels. Channels.

Chicago/Turabian
Stringer, Robin N, J. Lazniewska, and N. Weiss. “Transcriptomic Analysis of Glycan-Processing Genes in the Dorsal Root Ganglia of Diabetic Mice and Functional Characterization on Cav3.2 Channels.” Channels (2020).

MLA
Stringer, Robin N., et al. “Transcriptomic Analysis of Glycan-Processing Genes in the Dorsal Root Ganglia of Diabetic Mice and Functional Characterization on Cav3.2 Channels.” Channels, 2020.


Abstract

ABSTRACT Cav3.2 T-type calcium channels play an essential role in the transmission of peripheral nociception in the dorsal root ganglia (DRG) and alteration of Cav3.2 expression is associated with the development of peripheral painful diabetic neuropathy (PDN). Several studies have previously documented the role of glycosylation in the expression and functioning of Cav3.2 and suggested that altered glycosylation of the channel may contribute to the aberrant expression of the channel in diabetic conditions. In this study, we aimed to analyze the expression of glycan-processing genes in DRG neurons from a leptin-deficient genetic mouse model of diabetes (db/db). Transcriptomic analysis revealed that several glycan-processing genes encoding for glycosyltransferases and sialic acid-modifying enzymes were upregulated in diabetic conditions. Functional analysis of these enzymes on recombinant Cav3.2 revealed an unexpected loss-of-function of the channel. Collectively, our data indicate that diabetes is associated with an alteration of the glycosylation machinery in DRG neurons. However, individual action of these enzymes when tested on recombinant Cav3.2 cannot explain the observed upregulation of T-type channels under diabetic conditions. Abbreviations: Galnt16: Polypeptide N-acetylgalactosaminyltransferase 16; B3gnt8: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8; B4galt1: Beta-1,4-galactosyltransferase 1; St6gal1: Beta-galactoside alpha-2,6-sialyltransferase 1; Neu3: Sialidase-3